Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Børre Fevang
Adverse Events With Fatal Outcome Associated With Alemtuzumab Treatment in Multiple Sclerosis
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Case of Autoimmune Myositis After Treatment With Alemtuzumab for Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Immune Competence After Alemtuzumab Treatment of Multiple Sclerosis
Neurology
Neurology
Pnd66 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Cyprus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Pgi1 - Adverse Events Associated With the Treatment of Inflammatory Bowel Disease in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nellix Endobag Rupture Associated With a Fatal Outcome
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Hospital Costs Associated With Adverse Events in Gynecological Oncology
Gynecologic Oncology
Gynecology
Oncology
Obstetrics